Themis Medicare informs about outcome of board meeting

12 Feb 2021 Evaluate

Themis Medicare has informed that the Board of Directors at its meeting held today,12th February 2021, which commenced at 11.15 am and concluded at 2.30 pm, considered and approved the unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2020. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2020 is enclosed; and appointed SAV & Associates LLP as Secretarial Auditor for the financial year 2020-21 for the purpose of conducting Secretarial Audit.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

84.22 0.20 (0.24%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×